US-based biopharmaceutical company Insmed Incorporated (Nasdaq:INSM) announced on Thursday that it has received the highest ranking in Science journal's 2024 Top Employers Survey.

The annual survey polls employees in the biotechnology, pharmaceutical and related industries to choose the 20 best employers and their driving characteristics. The results were based on around 6,500 responses from individuals located primarily across North America, Europe, and Asia/Pacific Rim.

Will Lewis, Insmed chair and CEO, said: "It is a tremendous honour to have been named the No. 1 employer in Science's annual survey for the fourth consecutive year. This past year has been transformational for our company, as we've demonstrated the strength of our commercial and pipeline programmes, continued to fuel the innovation engine behind our early-stage research, and enhanced our culture while growing to more than 1,200 employees around the world."